Merger of Scarborough and North East Yorkshire Healthcare NHS Trust with York Teaching Hospital NHS Foundation Trust
Scarborough and North East Yorkshire Healthcare NHS Trust and York Teaching Hospital NHS Foundation Trust are proposing to merge.
Consistent with its merger guidelines, the CCP will examine the costs and benefits of the proposed merger of these acute trusts to patients and taxpayers, in order to ascertain whether the transaction is consistent with Principle 10 of the Principles and Rules for Cooperation and Competition. In doing so, the CCP will consider the effect of the transaction on patient choice and competition for acute services in North Yorkshire, York, East Riding of Yorkshire and any relevant surrounding area.
The CCP welcomes submissions in writing from interested individuals and organisations on this issue or any other matter relevant to the CCP’s assessment of this transaction under the Principles and Rules for Cooperation and Competition. To submit evidence please use the email address: cases@ccpanel.gsi.gov.uk.
The closing date for submissions is 7 November 2011.
Case documents
Timetable amendment (08/12/11) [136 KB]
Submission of Robert Peacock (21/11/11) [52 KB]
Additional assurances provided by Yorks and Humber SHA (17/10/11) [61 KB]
Assurances in Respect of Interim Management Arrangements (17/10/11) [118 KB]
Submission from York Teaching Hospital NHS Foundation Trust (17/10/11) [680 KB]
Notice of Acceptance (17/10/11) [192 KB]
Administrative timetable
| Event | Date |
|---|---|
| CCP publishes Notice of Acceptance | 17 October 2011 |
| Closing date for Phase I submissions | 7 November 2011 |
| Deadline for completion of Phase I* | 12 December 2011 |
| Deadline for completion of Phase II (if required)** | 13 February 2012 |
* At the end of Phase I, the CCP will either:
- recommend that the merger be allowed to proceed, or
- recommend that the merger be allowed to proceed subject to measures agreed with the parties that address concerns identified by the CCP during Phase I, or
- proceed to a more detailed Phase II investigation.
** Phase II allows the CCP to conduct a more in-depth investigation where this is required to fully assess a merger.
NB. This timetable will be updated as required during the course of the inquiry.
Copyright © 2009
